Makoto Aihara Selected Research

iganidipine

2/2006

Neuroprotective effect of calcium channel blocker against retinal ganglion cell damage under hypoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Makoto Aihara Research Topics

Disease

43	Glaucoma 03/2022 - 12/2004
26	Open-Angle Glaucoma (Glaucoma, Open Angle) 12/2021 - 06/2004
20	Ocular Hypertension (Glaucoma, Suspect) 03/2022 - 04/2003
12	Low Tension Glaucoma 08/2021 - 11/2006
9	Uveitis 01/2022 - 07/2017
8	Cataract (Cataracts) 03/2022 - 01/2018
8	Ganglion Cysts (Ganglion) 01/2022 - 04/2007
7	Inflammation (Inflammations) 01/2022 - 01/2018
7	Hypoxia (Hypoxemia) 12/2019 - 02/2006
4	Atrophy 10/2022 - 01/2009
4	Hyperemia 01/2022 - 01/2012
4	Fibrosis (Cirrhosis) 12/2021 - 09/2019
4	Exfoliation Syndrome 11/2021 - 03/2015
4	Blister (Bulla) 01/2021 - 07/2009
3	Macular Degeneration (Age-Related Maculopathy) 10/2022 - 01/2019
3	Keratoconus 01/2022 - 04/2010
3	Pterygium 01/2021 - 12/2008
3	Acute Retinal Necrosis Syndrome 01/2021 - 01/2020
3	Sarcoidosis (Schaumann Disease) 03/2020 - 01/2019
3	Endophthalmitis (Ophthalmia) 03/2020 - 01/2020
3	Necrosis 01/2019 - 01/2011
2	Corneal Edema 08/2022 - 01/2022
2	Premature Birth (Birth, Premature) 01/2022 - 12/2020
2	Blepharitis 01/2022 - 01/2021
2	Infections 01/2021 - 11/2020
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2021
2	Cicatrix (Scar) 01/2021 - 01/2017
2	Epiretinal Membrane (Epiretinal Membranes) 01/2021 - 10/2005
2	Keratitis 12/2020 - 01/2016
2	Rheumatoid Arthritis 03/2020 - 07/2018
2	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 03/2020 - 01/2019
2	Intraocular Lymphoma 01/2020 - 10/2017
2	Corneal Neovascularization 12/2019 - 11/2019
2	Choroidal Neovascularization 12/2019 - 11/2019
2	Optic Nerve Diseases (Optic Neuropathy) 03/2010 - 10/2003
2	Refractive Errors (Refractive Error) 01/2008 - 11/2006
1	Myopia 10/2022
1	Neoplasm Metastasis (Metastasis) 03/2022
1	Colorectal Neoplasms (Colorectal Cancer) 03/2022
1	Neoplasms (Cancer) 03/2022

Drug/Important Bio-Agent (IBA)

14	Retinaldehyde (Retinal)IBA 10/2022 - 08/2006
10	Ophthalmic Solutions (Eye Drops)IBA 01/2022 - 04/2010
10	Latanoprost (Xalatan)FDA Link 09/2021 - 04/2010
8	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 10/2021 - 08/2012
8	Neuroprotective AgentsIBA 01/2019 - 02/2006
7	ProstaglandinsIBA 11/2021 - 12/2017
7	Glutamic Acid (Glutamate)FDA Link 01/2021 - 05/2007
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2009
5	hydroxide ionIBA 03/2022 - 10/2014
5	Timolol (Blocadren)FDA LinkGeneric 11/2021 - 05/2007
5	omidenepag isopropylIBA 11/2021 - 01/2019
4	SteroidsIBA 08/2022 - 07/2018
4	Fluorescein (Funduscein)FDA LinkGeneric 01/2022 - 08/2018
4	K-115IBA 01/2021 - 10/2017
4	Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric 01/2020 - 12/2008
3	Carrier Proteins (Binding Protein)IBA 03/2022 - 01/2009
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2021 - 01/2020
3	prostaglandin F2alpha receptorIBA 09/2021 - 01/2018
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 08/2021 - 03/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2020
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 12/2019 - 01/2017
3	Travoprost (Travatan)FDA Link 01/2016 - 09/2011
3	N-Methylaspartate (NMDA)IBA 05/2009 - 04/2007
2	Melanins (Melanin)IBA 10/2022 - 11/2020
2	Carteolol (Carteolol Hydrochloride)FDA LinkGeneric 09/2021 - 05/2007
2	Glucose (Dextrose)FDA LinkGeneric 02/2021 - 01/2009
2	Long Noncoding RNAIBA 01/2021 - 11/2020
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2020 - 04/2007
2	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 10/2017
2	LysophospholipidsIBA 12/2019 - 01/2017
2	LipidsIBA 09/2019 - 07/2019
2	SphingosineIBA 09/2019 - 01/2017
2	rho-Associated KinasesIBA 01/2019 - 10/2017
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 03/2018 - 01/2009
2	lysophosphatidic acidIBA 01/2018 - 01/2018
2	Biological ProductsIBA 12/2017 - 10/2003
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2016 - 03/2011
2	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 10/2015 - 02/2010
2	tafluprostIBA 03/2014 - 03/2010
2	Antiglaucoma AgentsIBA 03/2013 - 08/2012
2	Bimatoprost (Lumigan)FDA Link 11/2011 - 09/2011
2	AntioxidantsIBA 01/2011 - 02/2010
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2009 - 10/2008
2	LigandsIBA 12/2009 - 10/2008
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2009 - 01/2009
2	Collagen Type I (Type I Collagen)IBA 06/2004 - 04/2003
1	CDX2 Transcription FactorIBA 03/2022

Therapy/Procedure

14	Trabeculectomy (Trabeculoplasty) 03/2022 - 07/2009
9	Lasers (Laser) 11/2019 - 10/2003
7	Therapeutics 09/2021 - 12/2017
3	Vitrectomy 01/2022 - 03/2018
3	Filtering Surgery 01/2021 - 01/2017
3	Light Coagulation 01/2012 - 10/2003
2	Drug Therapy (Chemotherapy) 03/2022 - 10/2017
2	Scleral Buckling 01/2022 - 01/2021
2	Contact Lenses 01/2022 - 06/2008
2	Phacoemulsification 05/2021 - 07/2020
2	Slit Lamp 12/2019 - 06/2008
1	Neoadjuvant Therapy 03/2022